The PSTI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PSTI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The PSTI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View PSTI Detailed Price Forecast - CNN Money||View PSTI Detailed Summary - Google Finance|
|View PSTI Detailed Summary - Yahoo! Finance||View PSTI Stock Research & Analysis - Zacks.com|
|View PSTI Trends & Analysis - Trade-Ideas||View PSTI Major Holders - Barrons|
|View PSTI Call Transcripts - NASDAQ||View PSTI Breaking News & Analysis - Seeking Alpha|
|View PSTI Annual Report - CompanySpotlight.com||View PSTI OTC Short Report - OTCShortReport.com|
|View PSTI Fundamentals - TradeKing||View PSTI SEC Filings - Bar Chart|
|View Historical Prices for PSTI - The WSJ||View Performance/Total Return for PSTI - Morningstar|
|View the Analyst Estimates for PSTI - MarketWatch||View the Earnings History for PSTI - CNBC|
|View the PSTI Earnings - StockMarketWatch||View PSTI Buy or Sell Recommendations - MacroAxis|
|View the PSTI Bullish Patterns - American Bulls||View PSTI Short Pain Metrics - ShortPainBot.com|
|View PSTI Stock Mentions - StockTwits||View PSTI Stock Mentions - PennyStockTweets|
|View PSTI Stock Mentions - Twitter||View PSTI Investment Forum News - Investor Hub|
|View PSTI Stock Mentions - Yahoo! Message Board||View PSTI Stock Mentions - Seeking Alpha|
|View Insider Transactions for PSTI - SECform4.com||View Insider Transactions for PSTI - Insider Cow|
|View PSTI Major Holdings Summary - CNBC||View Insider Disclosure for PSTI - OTC Markets|
|View Insider Transactions for PSTI - Yahoo! Finance||View Institutional Holdings for PSTI - NASDAQ|
|View PSTI Stock Insight & Charts - FinViz.com||View PSTI Investment Charts - StockCharts.com|
|View PSTI Stock Overview & Charts - BarChart||View PSTI User Generated Charts - Trading View|
Reminder- Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease Tomorrow
Posted on Thursday December 13, 2018
Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, will host a Key Opinion Leader (KOL) meeting on Peripheral Artery Disease (PAD) tomorrow, December 14, 2018 at 8am-9:30am EST, in New York City. The meeting will feature presentations by KOLs John Lantis, MD, Vice Chairman of the Department of Surgery and Chief of Vascular and Endovascular Surgery at Mount Sinai West, and Mary L. Yost, MBA, Co-Founder of The Sage Group, who will discuss the current treatment landscape and unmet medical needs, the economic impact, and potential market opportunities for treating patients with PAD.
Pluristem Therapeutics Enters into Cell Thawing Device License Agreement with Chart Industries, Inc.
Posted on Tuesday December 04, 2018
Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that it has entered into a license agreement with a subsidiary of Chart Industries, Inc. regarding Pluristem’s thawing device for cell-based therapies. Pluristem’s point-of-care thawing device technology is designed to allow for the precise and automated thawing of cells in a controlled and monitored environment, and is expected to result in the highest levels of cell viability and quality. The technology includes many advanced unique proprietary features which were designed to result in the leading thawing devices on the market.
Pluristem Presents Data from First Cohort in Ongoing Phase I Hematological Study at the American Society of Hematology (ASH) Annual Meeting
Posted on Monday December 03, 2018
Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that the Company presented data from the first cohort of patients in its ongoing Phase I clinical trial of PLX-R18 for the treatment of incomplete hematopoietic recovery following hematopoietic cell transplantation (HCT) at the American Society of Hematology (ASH) 60th Annual Meeting and Exposition, which is being held December 1-4 in San Diego.
Pluristem Therapeutics Sees Hammer Chart Pattern: Time to Buy?
Posted on Friday November 30, 2018
Pluristem Therapeutics has been struggling lately, but the selling pressure may be coming to an end soon.